MARKET

PSNL

PSNL

Personalis
NASDAQ
8.66
+0.83
+10.54%
Opening 14:18 02/10 EST
OPEN
8.53
PREV CLOSE
7.83
HIGH
8.89
LOW
8.35
VOLUME
1.07M
TURNOVER
--
52 WEEK HIGH
11.50
52 WEEK LOW
2.826
MARKET CAP
768.60M
P/E (TTM)
-9.8779
1D
5D
1M
3M
1Y
5Y
1D
Personalis Shares Rise After Lung Cancer Test Gets Medicare Coverage Approval
Dow Jones · 6h ago
Personalis rises on Medicare coverage for NeXT Personal cancer test
Seeking Alpha · 7h ago
BUZZ-U.S. STOCKS ON THE MOVE-Zimmer Biomet, Datadog​, Ecolab
Reuters · 8h ago
Personalis Gets Medicare Coverage For Lung Cancer Surveillance Test
Benzinga · 9h ago
Analysts Offer Insights on Healthcare Companies: Personalis (PSNL), Waters (WAT) and Alkermes (ALKS)
TipRanks · 10h ago
BUZZ-U.S. STOCKS ON THE MOVE-Vistra Corp, Quest Diagnostics, Jacobs Solutions
Reuters · 10h ago
Analysts Offer Insights on Healthcare Companies: CVRx (CVRX), Quest Diagnostics (DGX) and Personalis (PSNL)
TipRanks · 10h ago
BUZZ-U.S. STOCKS ON THE MOVE-Spotify, DuPont, Hasbro
Reuters · 12h ago
More
About PSNL
Personalis, Inc. is engaged in developing, marketing and selling advanced cancer genomic tests and analytics. The Company’s advanced genomic sequencing and analytics support the development of personalized cancer vaccines and other cancer immunotherapies. Its products include NeXT Personal, ImmunoI DNeXT, NeXT Personal Dx, NeXT Dx, whole exome sequencing (WES), and whole genome sequencing (WGS). NeXT Personal is a tumor-informed liquid biopsy test for the detection of minimal residual disease (MRD) and recurrence in cancer. NeXT Dx is a comprehensive tumor profiling test that is used to help select therapy for a cancer patient and identify potential clinical trials for a patient. The Company performed WGS on human samples for research projects, such as population sequencing initiatives. The Company’s tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and the development of personalized cancer therapies.

Webull offers Personalis Inc stock information, including NASDAQ: PSNL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PSNL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PSNL stock methods without spending real money on the virtual paper trading platform.